Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern

被引:40
作者
Tabaries, Sebastien [1 ,2 ]
Annis, Matthew G. [1 ,2 ]
Lazaris, Anthoula [3 ]
Petrillo, Stephanie K. [3 ]
Huxham, Jennifer [1 ,2 ]
Abdellatif, Amri [3 ]
Palmieri, Vincent [3 ]
Chabot, Jaclyn [3 ]
Johnson, Radia M. [4 ]
Van Laere, Steven [5 ,6 ]
Verhoef, Cornelis [7 ]
Hachem, Yasmina [1 ]
Yumeen, Sara [1 ]
Meti, Nicholas [1 ]
Omeroglu, Atilla [8 ]
Altinel, Gulbeyaz [8 ]
Gao, Zu-Hua [8 ]
Yu, Alan S. L. [9 ]
Grunhagen, Dirk J. [7 ]
Vermeulen, Peter [5 ,6 ]
Metrakos, Peter [3 ]
Siegel, Peter M. [1 ,2 ]
机构
[1] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada
[2] McGill Univ, Dept Med, Montreal, PQ, Canada
[3] McGill Univ, Dept Surg, Hlth Ctr, Montreal, PQ, Canada
[4] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA
[5] Univ Antwerp, Mol Imaging Pathol Radiotherapy & Oncol MIPRO, Antwerp, Belgium
[6] Oncol Ctr GZA, Translat Canc Res Unit, Antwerp, Belgium
[7] Erasmus MC Canc Inst, Dept Surg Oncol, Rotterdam, Netherlands
[8] McGill Univ, Dept Pathol, Hlth Ctr, Montreal, PQ, Canada
[9] Univ Kansas, Med Ctr, Jared Grantham Kidney Inst, Kansas City, KS 66103 USA
基金
加拿大健康研究院;
关键词
BREAST-CANCER; EXTRACELLULAR VESICLES; GASTRIC-CANCER; EXPRESSION; CELLS; RESISTANCE; EXOSOMES; TUMORIGENICITY; INFLAMMATION; INVASION;
D O I
10.1038/s42003-021-02189-9
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Claudin-2 promotes breast cancer liver metastasis by enabling seeding and early cancer cell survival. We now demonstrate that Claudin-2 is functionally required for colorectal cancer liver metastasis and that Claudin-2 expression in primary colorectal cancers is associated with poor overall and liver metastasis-free survival. We have examined the role of Claudin-2, and other claudin family members, as potential prognostic biomarkers of the desmoplastic and replacement histopathological growth pattern associated with colorectal cancer liver metastases. Immunohistochemical analysis revealed higher Claudin-2 levels in replacement type metastases when compared to those with desmoplastic features. In contrast, Claudin-8 was highly expressed in desmoplastic colorectal cancer liver metastases. Similar observations were made following immunohistochemical staining of patient-derived xenografts (PDXs) that we have established, which faithfully retain the histopathology of desmoplastic or replacement type colorectal cancer liver metastases. We provide evidence that Claudin-2 status in patient-derived extracellular vesicles may serve as a relevant prognostic biomarker to predict whether colorectal cancer patients have developed replacement type liver metastases. Such a biomarker will be a valuable tool in designing optimal treatment strategies to better manage patients with colorectal cancer liver metastases. Tabaries et al. describe that claudin 2 is a promoter of colorectal cancer liver metastasis. Furthermore, high Claudin-2 expression is associated with shorter time to liver-specific recurrence and is a biomarker of replacement type CRC liver metastases.
引用
收藏
页数:14
相关论文
共 75 条
[1]   Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity [J].
Agarwal, R ;
D'Souza, T ;
Morin, P .
CANCER RESEARCH, 2005, 65 (16) :7378-7385
[2]   Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice [J].
Ahmed, Sharif U. ;
Zair, Murtuza ;
Chen, Kui ;
Iu, Matthew ;
He, Feng ;
Adeyi, Oyedele ;
Cleary, Sean P. ;
Ghanekar, Anand .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (79) :e50544
[3]   Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas [J].
Aung, PP ;
Mitani, Y ;
Sanada, Y ;
Nakayama, H ;
Matsusaki, K ;
Yasui, W .
VIRCHOWS ARCHIV, 2006, 448 (04) :428-434
[4]   Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value [J].
Barnhill, Raymond ;
van Dam, Pieter-Jan ;
Vermeulen, Peter ;
Champenois, Gabriel ;
Nicolas, Andre ;
Rawson, Robert, V ;
Wilmott, James S. ;
Thompson, John F. ;
Long, Georgina, V ;
Cassoux, Nathalie ;
Roman-Roman, Sergio ;
Busam, Klaus J. ;
Scolyer, Richard A. ;
Lazar, Alexander J. ;
Lugassy, Claire .
JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2020, 6 (03) :195-206
[5]   Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases [J].
Barnhill, Raymond ;
Vermeulen, Peter ;
Daelemans, Sofie ;
van Dam, Pieter-Jan ;
Roman-Roman, Sergio ;
Servois, Vincent ;
Hurbain, Ilse ;
Gardrat, Sophie ;
Raposa, Graca ;
Nicolas, Andre ;
Dendale, Remi ;
Pierron, Gaelle ;
Desjardins, Laurence ;
Cassoux, Nathalie ;
Piperno-Neumann, Sophie ;
Mariani, Pascale ;
Lugassy, Claire .
JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2018, 4 (04) :227-240
[6]   Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients [J].
Bohlok, Ali ;
Vermeulen, Peter ;
Leduc, Sophia ;
Latacz, Emily ;
Botzenhart, Lara ;
Richard, Francois ;
De Schepper, Maxim ;
Geukens, Tatjana ;
Lucidi, Valerio ;
Ignatiadis, Michail ;
Aftimos, Philippe ;
Sotiriou, Christos ;
Piccart, Martine ;
Hendlisz, Alain ;
Van Laere, Steven ;
Dirix, Luc ;
Noel, Jean-Christophe ;
Biganzoli, Elia ;
Larsimont, Denis ;
Desmedt, Christine ;
Donckier, Vincent .
NPJ BREAST CANCER, 2020, 6 (01)
[7]   Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis [J].
Bu, Pengcheng ;
Chen, Kai-Yuan ;
Xiang, Kun ;
Johnson, Christelle ;
Crown, Scott B. ;
Rakhilin, Nikolai ;
Ai, Yiwei ;
Wang, Lihua ;
Xi, Rui ;
Astapova, Inna ;
Han, Yan ;
Li, Jiahe ;
Barth, Bradley B. ;
Lu, Min ;
Gao, Ziyang ;
Mines, Robert ;
Zhang, Liwen ;
Herman, Mark ;
Hsu, David ;
Zhang, Guo-Fang ;
Shen, Xiling .
CELL METABOLISM, 2018, 27 (06) :1249-+
[8]   Symplekin promotes tumorigenicity by up-regulating claudin-2 expression [J].
Buchert, Michael ;
Papin, Marina ;
Bonnans, Caroline ;
Darido, Charbel ;
Raye, Warren S. ;
Garambois, Veronique ;
Pelegrine, Andre ;
Bourgaux, Jean-Francois ;
Pannequin, Julie ;
Joubert, Dominique ;
Hollande, Frederic .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (06) :2628-2633
[9]   Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges [J].
Buikhuisen, Joyce Y. ;
Torang, Arezo ;
Medema, Jan Paul .
ONCOGENESIS, 2020, 9 (07)
[10]   Pan-cancer analysis of whole genomes [J].
Campbell, Peter J. ;
Getz, Gad ;
Korbel, Jan O. ;
Stuart, Joshua M. ;
Jennings, Jennifer L. ;
Stein, Lincoln D. ;
Perry, Marc D. ;
Nahal-Bose, Hardeep K. ;
Ouellette, B. F. Francis ;
Li, Constance H. ;
Rheinbay, Esther ;
Nielsen, G. Petur ;
Sgroi, Dennis C. ;
Wu, Chin-Lee ;
Faquin, William C. ;
Deshpande, Vikram ;
Boutros, Paul C. ;
Lazar, Alexander J. ;
Hoadley, Katherine A. ;
Louis, David N. ;
Dursi, L. Jonathan ;
Yung, Christina K. ;
Bailey, Matthew H. ;
Saksena, Gordon ;
Raine, Keiran M. ;
Buchhalter, Ivo ;
Kleinheinz, Kortine ;
Schlesner, Matthias ;
Zhang, Junjun ;
Wang, Wenyi ;
Wheeler, David A. ;
Ding, Li ;
Simpson, Jared T. ;
O'Connor, Brian D. ;
Yakneen, Sergei ;
Ellrott, Kyle ;
Miyoshi, Naoki ;
Butler, Adam P. ;
Royo, Romina ;
Shorser, Solomon, I ;
Vazquez, Miguel ;
Rausch, Tobias ;
Tiao, Grace ;
Waszak, Sebastian M. ;
Rodriguez-Martin, Bernardo ;
Shringarpure, Suyash ;
Wu, Dai-Ying ;
Demidov, German M. ;
Delaneau, Olivier ;
Hayashi, Shuto .
NATURE, 2020, 578 (7793) :82-+